STN: BL 125546 Proper Name: Meningococcal Group B Vaccine Trade Name: BEXSERO Manufacture: GlaxoSmithKline Indication:
Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age.
Product Information
Supporting Documents
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
